With the U.S. dealing with a slumping economy, which some have already declared a recession, venture capitalists and other investors in the life sciences industry might be less willing to take risks, said Donald Elmer, managing partner of Seattle-based Pacific Horizon Ventures. (BioWorld Financial Watch)